Oral mucosal lesions that are
associated with HIV infection can play an important role in guiding the
decision to initiate antiretroviral therapy (ART). The incidence of these
lesions relative to the timing of ART initiation has not been well characterized.
A randomized controlled clinical trial was conducted at the GHESKIO Center in
Port-au-Prince, Haiti between 2004 and 2009. 816 HIV-infected ART-naïve
participants with CD4 T cell counts between 200 and 350 cells/mm3 were randomized to either immediate ART initiation
(early group; N = 408), or initiation when CD4 T cell count was less than or
equal 200 cells/mm3 or with the development of an AIDS-defining condition
(delayed group; N = 408). Every 3 months, all participants underwent an oral
examination.
The incidence of oral lesions was 4.10 in the early group and
17.85 in the delayed group (p-value <0.01). In comparison to the early
group, there was a significantly higher incidence of candidiasis, hairy
leukoplakia, herpes labialis, and recurrent herpes simplex in the delayed
group. The incidence of oral warts in delayed group was 0.97 before therapy and
4.27 post-ART initiation (p-value <0.01). In the delayed group the incidence
of oral warts post-ART initiation was significantly higher than that seen in
the early group (4.27 versus 1.09; p-value <0.01).
The incidence of oral
warts increased after ART was initiated, and relative to the early group there
was a four-fold increase in oral warts if ART was initiated following an AIDS
diagnosis. Based upon our findings, candidiasis, hairy leukoplakia, herpes
labialis, and recurrent herpes simplex indicate immune suppression and the need
to start ART. In contrast, oral warts are a sign of immune reconstitution
following ART initiation.
Below:
Full article at: http://goo.gl/W2pd06
By:
Weill Cornell Medical Center, New York, New York, United States of America
Groupe Haitien d’Etude du Sarcome de Kaposi et des Infections Opportunistes
(GHESKIO), Port-au-Prince, Haiti
University of California San Francisco School of Dentistry, San Francisco,
California, United States of America
More at: https://twitter.com/hiv insight
No comments:
Post a Comment